In the peripheral blood of GDM patients, lncRNA RPL13P5 forms a co-expression chain with the TSC2 gene through the PI3K-AKT signaling pathway as part of the insulin resistance process in GDM. This evidence concerns the gene RPL13P5 and gestational diabetes.